Medicare’s National Coverage Decisions For Technologies, 1999–2007
- 1 November 2008
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 27 (6), 1620-1631
- https://doi.org/10.1377/hlthaff.27.6.1620
Abstract
An analysis of Medicare national coverage decisions (NCDs) from 1999 through 2007 reveals that the Centers for Medicare and Medicaid Services (CMS) considers the available evidence as no better than fair for most of the technologies considered. Still, the CMS issues favorable decisions in 60 percent of the cases it takes on, although almost always with conditions placed on coverage. Since enactment of the 2003 Medicare Modernization Act, which legislated maximum review times for NCDs, the CMS has eliminated “long duration” decisions (more than one year) and has issued several “coverage with evidence development” decisions, which promise flexibility but also carry implementation challenges.Keywords
This publication has 11 references indexed in Scilit:
- The Impact of Medicare Coverage Policies on Health Care UtilizationHealth Services Research, 2008
- Key principles for the improved conduct of health technology assessments for resource allocation decisionsInternational Journal of Technology Assessment in Health Care, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Medicare’s Coverage Of Colorectal Cancer Drugs: A Case Study In Evidence Development And PolicyHealth Affairs, 2006
- Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’Health Affairs, 2006
- Biotechnology And Medicare’s New Technology Policy: Lessons From Three Case StudiesHealth Affairs, 2006
- Medicare's Requirement for Research Participation as a Condition of CoveragePublished by American Medical Association (AMA) ,2006
- AcknowledgmentsHealth Affairs, 2006
- Medicare’s National Coverage Decisions, 1999–2003: Quality Of Evidence And Review TimesHealth Affairs, 2005
- Evidence-Based Medicine And Policy: The Case Of The Implantable Cardioverter DefibrillatorHealth Affairs, 2005